Atlas Trials

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Clinical trial NCT00719212 · COMPLETED

Trial details

NCT number
NCT00719212
Sponsor
Translational Research in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Neoplasms
Start date
2009-01-01
Primary completion
2013-05-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.